-
psnet.ahrq.gov/perspective/using-human-factors-engineering-and-seips-model-advance-patient-safety-care-transitions
November 16, 2022 - Using Human Factors Engineering and the SEIPS Model to Advance Patient Safety in Care Transitions
Pascale Carayon, PhD; Nicole Werner, PhD; Anita Makkenchery, MPH; Sarah E. Mossburg, RN, PhD
| November 16, 2022
Also Read the Conversation
View more articles from the same aut…
-
digital.ahrq.gov/sites/default/files/docs/citation/r03hs028693-rajamani-final-report-2023.pdf
January 01, 2023 - Advancing Population and Public health Reporting and Outcomes with Vaccination data Exchange (APPROVE) – Final Report
1
AHRQ Grant Final Progress Report
Title of Project:
Advancing Population and Public health Reporting and Outcomes with Vaccination data
Exchange (APPROVE)
Principal Investigator and Team M…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/pdi/b4_pdi_documentationcoding.pdf
March 15, 2016 - Documentation and Coding for the AHRQ Pediatric Quality Indicators
Pediatric Toolkit for Using the AHRQ Quality Indicators
How To Improve Hospital Quality and Safety
Tool B.4 i
Documentation and Coding for the AHRQ
Pediatric Quality Indicators
Note: This tool was updated based on test software provided by AHR…
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics
January 01, 2023 - Health Information Technology Center for Education and Research on Therapeutics
Project Final Report ( PDF , 564.63 KB) Disclaimer
Disclaimer
The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily re…
-
psnet.ahrq.gov/web-mm/dangers-missing-epidural-abscess-multiple-visits-and-delayed-diagnosis-severely-negative
April 27, 2022 - SPOTLIGHT CASE
Dangers of Missing an Epidural Abscess: Multiple Visits and Delayed Diagnosis with a Severely Negative Outcome
Citation Text:
Lantz L, Yoon J, Barnes DK. Dangers of Missing an Epidural Abscess: Multiple Visits and Delayed Diagnosis with a Severely Negative Outcome. PSNet [internet…
-
www.ahrq.gov/news/events/nac/2020-07-nac/nacmtg071420-minutes.html
November 01, 2020 - Meeting Minutes, July 2020
National Advisory Council
Minutes from the July 14, 2020, meeting of the Agency for Healthcare Research and Quality's National Advisory Council.
( Virtual Meeting )
Contents
Summary
Call to Order and Approval of March 26, 2020, Meeting Summary
Overview and Recent Accomplis…
-
www.ahrq.gov/sites/default/files/wysiwyg/news/events/nac/2020-07-nac/nacminutes-071420.pdf
January 01, 2020 - National Advisory Council Meeting, July 14, 2020: Minutes
National Advisory Council, July 14, 2020 Page 1
Agency for Healthcare Research and Quality
National Advisory Council Meeting
(Virtual Meeting)
July 14, 2020
SUMMARY
NAC Members Present
Tina M. Hernandez-Boussard, Ph.D., M.…
-
digital.ahrq.gov/sites/default/files/docs/citation/k01hs021531-ancker-final-report-2018.pdf
January 01, 2018 - Improving Healthcare Quality with User-Centered Patient Portals - Final Report
1. …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
December 01, 2009 - Layout 1
Background
Breast cancer is the second most common
malignancy of women, with over 180,000
new cases diagnosed each year in the
United States. Survival rates depend on the
stage of disease at diagnosis. Women
diagnosed with early stages of breast
cancer have a 5-year survival rate near 100
percent. However, …
-
cdsic.ahrq.gov/sites/default/files/2024-09/Final%20IAS%20PC%20CDS%20Case%20Studies%20Report_2.pdf
January 01, 2024 - One project used simulated clinical scenarios where the patients received
two short clinical vignettes … more than 65 percent of patients; both issues contributing
to data for half of the patient use case scenarios … Usability was rated above average, and time-on-task decreased significantly between
the first and second scenarios
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
October 01, 2014 - There is the possibility that these types of clinical scenarios merit
different types of imaging.
-
digital.ahrq.gov/sites/default/files/docs/citation/09-10-0091-2-EF.pdf
October 01, 2009 - Reading, MA: Addison Wesley; Decisions about critical events in device-related
2004. p. 672. scenarios
-
www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/module1-presenters-notes.pdf
January 12, 2022 - is the primary tool for trainees to complete
the course activities, such as exercises, case‐based scenarios
-
www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/module1-introduction.pptx
January 12, 2022 - Workbook is the primary tool for trainees to complete the course activities, such as exercises, case‐based scenarios
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/mx2Ko29RH46mTYb36f-UBe
June 20, 2023 - (When direct evidence is
limited, absent, or restricted to select
populations or clinical scenarios,
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Dofv_5wDUQYVkoSDbX6Zse
May 25, 2021 - When direct evidence is limited, absent, or restricted to select populations
or clinical scenarios, the
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/YSDv4kYjdr7xnL3yLz2aSx
December 27, 2019 - When direct evidence is limited, absent, or restricted to select populations or clinical scenarios,
the
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-screening-using-nontraditional-risk-assessment
July 10, 2018 - When direct evidence is limited, absent, or restricted to select populations or clinical scenarios, the
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/decision-modeling-for-uspstf_0.pdf
July 01, 2016 - minimum eligibility age of 55 y and maximum of 80 y at different smoking eligibility cutoffs and
NLST scenarios
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening
September 14, 2021 - When direct evidence is limited, absent, or restricted to select populations or clinical scenarios, the